Clinical Trial Update: Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine [Phase 2]

View source ↗

Summary

Phase 2 trial results update on intranasal ketorolac for acute treatment of migraine shows efficacy and safety data; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sprix intranasal ketorolac (ketorolac trometamol)

Snippet

Sponsor: Egalet Ltd | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2016-09-30